104 related articles for article (PubMed ID: 12047372)
1. Human immunoglobulin A (IgA)-specific ligands from combinatorial engineering of protein A.
Rönnmark J; Grönlund H; Uhlén M; Nygren PA
Eur J Biochem; 2002 Jun; 269(11):2647-55. PubMed ID: 12047372
[TBL] [Abstract][Full Text] [Related]
2. Anti-idiotypic protein domains selected from protein A-based affibody libraries.
Eklund M; Axelsson L; Uhlén M; Nygren PA
Proteins; 2002 Aug; 48(3):454-62. PubMed ID: 12112671
[TBL] [Abstract][Full Text] [Related]
3. Affibody-beta-galactosidase immunoconjugates produced as soluble fusion proteins in the Escherichia coli cytosol.
Rönnmark J; Kampf C; Asplund A; Höidén-Guthenberg I; Wester K; Pontén F; Uhlén M; Nygren PA
J Immunol Methods; 2003 Oct; 281(1-2):149-60. PubMed ID: 14580889
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human factor VIII-specific affinity ligands selected from phage-displayed combinatorial libraries of protein A.
Nord K; Nord O; Uhlén M; Kelley B; Ljungqvist C; Nygren PA
Eur J Biochem; 2001 Aug; 268(15):4269-77. PubMed ID: 11488921
[TBL] [Abstract][Full Text] [Related]
5. High-affinity binding to staphylococcal protein A by an engineered dimeric Affibody molecule.
Lindborg M; Dubnovitsky A; Olesen K; Björkman T; Abrahmsén L; Feldwisch J; Härd T
Protein Eng Des Sel; 2013 Oct; 26(10):635-44. PubMed ID: 23924760
[TBL] [Abstract][Full Text] [Related]
6. Affinity maturation of a Taq DNA polymerase specific affibody by helix shuffling.
Gunneriusson E; Nord K; Uhlén M; Nygren P
Protein Eng; 1999 Oct; 12(10):873-8. PubMed ID: 10556248
[TBL] [Abstract][Full Text] [Related]
7. Inclusion of a non-immunoglobulin binding protein in two-site ELISA for quantification of human serum proteins without interference by heterophilic serum antibodies.
Andersson M; Rönnmark J; Areström I; Nygren PA; Ahlborg N
J Immunol Methods; 2003 Dec; 283(1-2):225-34. PubMed ID: 14659914
[TBL] [Abstract][Full Text] [Related]
8. Phage-based molecular directed evolution yields multiple tandem human IgA affibodies with intramolecular binding avidity.
Cao J; Wen ZM; Deng SH; Zhou X; Chen QL; Liao WT; Jiang SH; Jia JA; Qi ZT; Sun SH; Pan W
J Biotechnol; 2012 Apr; 158(3):120-7. PubMed ID: 21219944
[TBL] [Abstract][Full Text] [Related]
9. Selection and characterization of Affibody ligands to the transcription factor c-Jun.
Lundberg E; Brismar H; Gräslund T
Biotechnol Appl Biochem; 2009 Jan; 52(Pt 1):17-27. PubMed ID: 18260830
[TBL] [Abstract][Full Text] [Related]
10. Ribosome display selection of a murine IgG₁ Fab binding affibody molecule allowing species selective recovery of monoclonal antibodies.
Grimm S; Yu F; Nygren PÅ
Mol Biotechnol; 2011 Jul; 48(3):263-76. PubMed ID: 21197589
[TBL] [Abstract][Full Text] [Related]
11. Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides.
Grönwall C; Jonsson A; Lindström S; Gunneriusson E; Ståhl S; Herne N
J Biotechnol; 2007 Jan; 128(1):162-83. PubMed ID: 17088007
[TBL] [Abstract][Full Text] [Related]
12. Tailor-making a protein a-derived domain for efficient site-specific photocoupling to Fc of mouse IgG₁.
Yu F; Järver P; Nygren PÅ
PLoS One; 2013; 8(2):e56597. PubMed ID: 23424669
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcal surface display of immunoglobulin A (IgA)- and IgE-specific in vitro-selected binding proteins (affibodies) based on Staphylococcus aureus protein A.
Gunneriusson E; Samuelson P; Ringdahl J; Grönlund H; Nygren PA; Ståhl S
Appl Environ Microbiol; 1999 Sep; 65(9):4134-40. PubMed ID: 10473426
[TBL] [Abstract][Full Text] [Related]
14. Affibody-mediated transferrin depletion for proteomics applications.
Grönwall C; Sjöberg A; Ramström M; Höidén-Guthenberg I; Hober S; Jonasson P; Ståhl S
Biotechnol J; 2007 Nov; 2(11):1389-98. PubMed ID: 17639529
[TBL] [Abstract][Full Text] [Related]
15. A synthetic ligand for IgA affinity purification.
Palombo G; De Falco S; Tortora M; Cassani G; Fassina G
J Mol Recognit; 1998; 11(1-6):243-6. PubMed ID: 10076848
[TBL] [Abstract][Full Text] [Related]
16. Binding of human IgA myeloma proteins to protein A. Evidence for different binding mechanisms.
Biewenga J; Daus F; Modderman ML; Bruin GM
Immunol Commun; 1982; 11(3):189-200. PubMed ID: 7141462
[TBL] [Abstract][Full Text] [Related]
17. Affibody protein capture microarrays: synthesis and evaluation of random and directed immobilization of affibody molecules.
Renberg B; Shiroyama I; Engfeldt T; Nygren PK; Karlström AE
Anal Biochem; 2005 Jun; 341(2):334-43. PubMed ID: 15907880
[TBL] [Abstract][Full Text] [Related]
18. Protein engineering of an IgG-binding domain allows milder elution conditions during affinity chromatography.
Gülich S; Uhlén M; Hober S
J Biotechnol; 2000 Jan; 76(2-3):233-44. PubMed ID: 10656338
[TBL] [Abstract][Full Text] [Related]
19. Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand.
Wållberg H; Löfdahl PK; Tschapalda K; Uhlén M; Tolmachev V; Nygren PK; Ståhl S
Protein Expr Purif; 2011 Mar; 76(1):127-35. PubMed ID: 21029777
[TBL] [Abstract][Full Text] [Related]
20. Human IgA-binding peptides selected from random peptide libraries: affinity maturation and application in IgA purification.
Hatanaka T; Ohzono S; Park M; Sakamoto K; Tsukamoto S; Sugita R; Ishitobi H; Mori T; Ito O; Sorajo K; Sugimura K; Ham S; Ito Y
J Biol Chem; 2012 Dec; 287(51):43126-36. PubMed ID: 23076147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
